PRM60 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for 1st- Line Chronic Myeloid Leukaemia

M. Hoyle,T. Pavey,O. Ciani, L. Crathorne,T. Jones-Hughes,C. Cooper, L. Osipenko, M. Venkatachalam,C. Rudin,O. Ukoumunne,R. Garside, R. Anderson

VALUE IN HEALTH(2012)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要